Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Researchers from the University of Birmingham reported that the ELSA feasibility trial screened roughly 17,000 UK children aged three to 13 using a finger‑prick autoantibody test, identifying early‑stage type 1 diabetes before symptoms appear. The study found 75 children with a single autoantibody and 160 with multiple autoantibodies, and seven undiagnosed cases were started on insulin immediately. Results suggest a national screening programme could prevent up to 25% of diabetic ketoacidosis cases and enable timely treatment with drugs like Sanofi’s Teizeild. The team is expanding to older ages and evaluating cost‑effectiveness for NHS rollout.
Bristol Myers Squibb has teamed with Microsoft to embed FDA‑cleared AI radiology algorithms into Microsoft’s Precision Imaging Network, aiming to spot lung nodules earlier and streamline radiology workflows. The collaboration leverages a platform already used by more than 80% of...
The piece contrasts academic and biotech research cultures, highlighting how each handles uncertainty. Academic labs prioritize deep exploration and iterative validation, treating ambiguous results as opportunities for further inquiry. Biotech startups focus on data that can drive decisions quickly, balancing...
Mansoor Amiji, a Tanzanian‑born nanomedicine researcher, was named a Fellow of the National Academy of Inventors in December 2025, recognizing three decades of vaccine and drug‑delivery innovations. Simultaneously, a deep‑dive review reveals 31 of his publications flagged on PubPeer for image...
Next‑generation targeting chimeras (TACs) are moving from research labs to early clinical programs, signaling a new wave of induced‑proximity therapeutics beyond PROTACs. GSK’s $2.2 billion acquisition of Rapt Therapeutics adds a China‑origin allergy platform to its pipeline, highlighting strategic biotech buyouts....
Scientists at Trinity College Dublin discovered that microglial activity in the brain drives infantile amnesia in young mice. By pharmacologically suppressing microglia during a critical post‑natal window, the researchers observed heightened memory retention of a fearful task. Suppressed microglia led...
In the fourth quarter of 2025, biotech megacap companies—those valued at $10 billion or more—delivered a median stock price increase of 10%, adding $138.4 billion in market value. Over the full year, these megacaps posted the strongest performance, with a median gain...
Researchers at Wenzhou Medical University have engineered size‑evolving nanoparticles that can be administered as eye drops to deliver the anti‑VEGF protein bevacizumab to the retina. The particles begin at roughly 214 nm, linger on the ocular surface, and shrink to about...
Researchers at the University of St Andrews have released PoseR, an AI plug‑in that automatically reads animal movement from video and generates human‑readable behavior descriptions. The tool leverages graph neural networks to model animal shapes, dramatically reducing the time required for...
In this episode, Tom Shani, CEO and co‑founder of ProPhet, explains how AI—particularly machine learning models, transformers, and novel molecular representations—is transforming small‑molecule drug discovery by tackling slow timelines, high failure rates, and massive R&D costs. He shows how AI...
Researchers engineered bispecific nanobodies that tether to airway mucus, creating a localized barrier against respiratory viruses. In mouse models, the mucus‑anchored nanobodies dramatically lowered H1N1 influenza titers in nasal passages, trachea and lungs. In a hamster cohousing experiment, a single...
A new Nature Food study by Plinke, Sureth and Kalkuhl shows that applying carbon pricing or reforming value‑added tax (VAT) on food could markedly lower Europe’s food‑related greenhouse‑gas emissions. Quantitative analysis predicts higher prices on carbon‑intensive items will curb demand...
Congress is moving a bipartisan spending package that would reauthorize pediatric priority review vouchers, safeguard NIH funding, and extend Medicare coverage to multi‑cancer early‑detection tests. The House Appropriations Committee released a bill to fund the government through September and avoid...
In case you missed it, one apparent winner in today's bipartisan healthcare deal is the diagnostics firm Grail. $GRAL The company’s "multi-cancer early detection" test is already available, but in order to succeed it must leap multiple hurdles, including receiving...
Datwyler, LTS Device Technologies, and Stevanato Group announced a strategic partnership to create an integrated platform for self‑administered large‑volume subcutaneous biologics. The solution combines Stevanato’s EZ‑fill® 10‑20 mL cartridges, Datwyler’s NeoFlex™ spray‑coated plungers, and LTS’s Sorrel wearable injector, targeting doses up...
Yale researchers used an air‑liquid interface organoid of human nasal epithelium to show that a rapid interferon (IFN) response limits rhinovirus infection to less than 2% of cells, while blocking IFN triggers widespread viral replication. The study also identified a...
Researchers at Switzerland’s WSL used drone‑borne multispectral cameras to map drought stress across seven native tree species during the hot summer of 2023. By measuring photoprotective pigment signals and canopy greenness, they identified species‑specific responses, such as rapid oak recovery...
A Cornell‑Granada team created a synthetic DNA tracer to map environmental DNA (eDNA) transport in freshwater. They released 1 µg of the tracer in Cayuga Lake, tracked its dispersion for 33 hours, and built a hydrodynamic model that predicts eDNA source locations....
Proteolysis‑targeting chimeras (PROTACs) are leveraging the ubiquitin‑proteasome system to degrade disease‑causing proteins, opening treatment avenues for previously undruggable targets such as aggressive childhood cancers and resistant triple‑negative breast cancer. Major pharmaceutical companies—including Amgen, BMS, J&J, AbbVie, AstraZeneca and Novartis—have advanced...
The U.S. House will vote on a bipartisan continuing resolution to keep the federal government operating beyond Jan. 30, bundling sweeping pharmacy‑benefit‑manager (PBM) reforms and a reauthorization of the children's health voucher program. The PBM provisions aim to increase pricing transparency,...
Researchers discovered that overexpressing protein disulfide isomerase (PDI) restores contractile function in aged vascular smooth muscle. The study links age‑related loss of sulfenylation‑dependent actin remodeling to reduced arterial stiffness. In murine models, PDI overexpression re‑established F‑actin assembly and rescued vessel...
The European Parliament approved amendments to the Critical Medicines Act, introducing stricter drug‑stockpiling requirements and new financial incentives for manufacturers. The legislation mandates a minimum safety‑stock level—roughly 5 % of a product’s annual EU consumption—and tighter reporting on supply‑chain data. Companies...
Valneva announced the withdrawal of its chikungunya vaccine from the United States, removing the product from the market and suspending a post‑marketing study. The decision follows internal safety assessments and regulatory feedback. The company has not provided detailed efficacy data,...
Bispecific antibody programs are increasingly confronting early platform decisions that were once deemed interchangeable. Choices made to simplify development or streamline regulatory pathways have embedded mechanistic assumptions that now limit efficacy ceilings and differentiation. As multiple immuno‑oncology bispecifics converge on...
Researchers at Ben‑Gurion University have introduced a contextual AI system that translates label‑free microscope images into virtual fluorescent stains, dramatically improving accuracy. By feeding the model metadata such as cell shape, neighborhood, and colony position, the AI can correctly label...
Researchers introduced a pH‑responsive nanoplatform—PSO/ZIF‑8@PDA (PZP) nanoparticles—that couples photothermal activity with controlled psoralen release. The system degrades rapidly in acidic, infection‑laden bone tissue, delivering antibacterial action first, then promoting osteogenesis as the environment normalizes. In vitro studies identified an optimal...
West Pharmaceutical Services introduced the Synchrony S1 prefillable syringe system at Pharmapack 2026, targeting biologics and combination products. The platform offers 1 ml and 2.25 ml staked‑needle options as well as Luer‑lock configurations, paired with NovaPure and FluroTec barrier‑film plungers. By delivering a single‑source,...
Novo Nordisk and Aspect Biosystems have entered a new partnership phase to develop curative cellular medicines for diabetes. Aspect will acquire Novo Nordisk's stem‑cell‑derived islet and hypoimmune technologies and lead development, manufacturing, and commercialization, while Novo Nordisk retains rights to...
Leading physician organizations have filed a federal lawsuit seeking to overturn the CDC’s recent overhaul of the U.S. childhood vaccine schedule. The groups contend the new recommendations are reckless and lack adequate safety evidence. The legal challenge targets the addition...
Longevity biotech now targets root causes rather than single diseases. This is a paradigm shift in medicine
Inovalon introduced a Clinical Trial Eligibility Screener, an API that evaluates patient eligibility in real time using longitudinal primary source data. The service applies natural language processing to parse free‑text inclusion and exclusion criteria, delivering pass, fail or inconclusive results...
The provided input contains only a list of article titles, dates, and thumbnail descriptions without any substantive article text, author information, or detailed content.
Johnson & Johnson’s Janssen Biotech unit has entered a cross‑modality, multi‑target research collaboration with Isomorphic Labs, the Alphabet‑backed AI drug‑discovery start‑up. The partnership combines Isomorphic’s planet‑scale computing and AI‑driven design engine with J&J’s experimental and development capabilities, covering both small‑molecule...
In 2025 pharmaceutical packaging moved from simple containment to active protection, with functional materials that mitigate moisture, oxygen and impurity risks. Companies are embedding safety features such as child resistance directly into paperboard, while sustainability mandates drive mono‑material, recyclable designs....
A multi‑center genomic study has pinpointed five mitochondrial genes that significantly increase the risk of necrotizing enterocolitis (NEC) in preterm infants. Researchers analyzed DNA from over 1,200 neonates and correlated gene expression patterns with clinical outcomes, revealing a clear mitochondrial...
Hepatitis B infects about 254 million people and caused 1.1 million deaths in 2022, with chronic infection leading to cirrhosis and liver cancer. Researchers are pursuing a “functional cure”—sustained undetectable HBV DNA and loss of HBsAg—through novel antivirals, antisense oligonucleotides, and therapeutic...
Cytokinetics’ aficamten (Myqorzo®) received FDA approval as an oral cardiac myosin inhibitor for obstructive hypertrophic cardiomyopathy (oHCM). The drug is a next‑generation, reversible, allosteric inhibitor designed to simplify dose‑titration compared with the existing agent mavacamten. In a Phase 3 trial, aficamten...
$CRVS +57% premarket on AD Cohort-4: randomized PBO-controlled signal (EASI-75 75%, mean EASI −72% vs −40% PBO; p=0.035) with clean safety, real but fragile (n=12 vs 12; 10 PBO-evaluable). 📝No skin-biopsy disclosed. While exiting progress serum PD != tissue reversal....
Would the #CDC's principal deputy director view it as a public health loss for the US if the country loses its #measles elimination status? "Not really," Dr. Ralph Abraham said at a press conference today. https://t.co/JXb3tlOrsu
Pfizer has committed $30 million upfront and up to $500 million in milestone payments to partner with Novavax, gaining a non‑exclusive license to the Matrix‑M adjuvant technology. The agreement allows Pfizer to apply the adjuvant to up to two disease areas, though...
RFK Jr. is moving to remake a panel involved in that compensating people who are injured by vaccines. It could have big consequences. By @ChelseaCirruzzo. https://t.co/S98hMN6Vd0
Decoding the spatial dynamics of tumor and immune cell interactions in solid cancers https://t.co/AHgt77Ee2t https://t.co/1Xxkt45JlD
Pfizer is selling its ViiV Healthcare stake for $1.875 billion, reducing its involvement in the HIV joint venture. Shionogi’s ownership more than doubles to 21.7% while GSK retains a 78.3% majority and aims to push ViiV sales beyond £7 billion this year....
Are you ready to level up your bioinformatics skills? Let’s talk about repetition—a key concept that can save you hours in real-world data analysis. https://t.co/2Dtc9hz46e
Shared clinical decision making was devised to help patients & their doctors make choices when the answer isn't clear cut. People who devised the approach fear it's being hijacked to undermine decades of study supporting #vaccines, @EricBoodman writes. https://t.co/JMmaHTI7eg
Researchers at the University of Cambridge and Beihang University unveiled Revoice, an AI‑powered wearable choker that translates silently mouthed words into speech for stroke survivors with dysarthria. The non‑invasive device senses throat vibrations and carotid pulse, then uses two AI...
Vaccine proponents worry that Kennedy will drive manufacturers from the US market by adding autism to the vaccine injury compensation program & unleashing a flood of litigation. The path to that change is through a committee he's currently "acip-ing." (clearing...
You’re analyzing 10x Genomics single-cell RNA-seq and notice lots of intronic reads. Wait—wasn’t this a 3′ UMI-based assay for mature mRNA? Let’s unpack why introns show up—and why they matter. 🧵 https://t.co/cDeb8dfLAS
A new near‑infrared II (NIR‑II) imaging platform has demonstrated unprecedented clarity in visualizing liver tumors, achieving sub‑millimeter resolution at depths up to five centimeters. In early‑phase clinical trials, the technology identified lesions 30% earlier than conventional ultrasound and MRI, enabling...
A research team announced a novel catalytic method that forms carbon‑nitrogen (C‑N) bonds directly from water‑based nitrogen sources, eliminating the need for hazardous ammonia gas. The process operates under ambient temperature and pressure, achieving yields above 85% for a broad...
